Nexam Chemicals Patent Application Regarding PETA is Approved in Taiwan.


Nexam Chemical has received a notice of allowance from the patent office in Taiwan stating that it intends to grant the companys patent application for PETA, which is a unique and for Nexam Chemical very important product for crosslinking a large number of polymers.



PETA is a new and unique molecule that improves the properties of e.g. polyimides, nylons and polyesters. Nexam Chemical developed PETA with the aim of getting a crosslinker with lower curing temperature. Global production of plastics where PETA could be used comprises more than 20 million tons / year.



PETA is being evaluated by a large number of potential customers, whereof several are world leading in their respective areas. It concerns e.g. electronics applications, increased efficiency and improvement of manufacturing processes, and improvement of temperature resistance and service life of the materials.



As previously announced, the corresponding European and US applications has also been granted. The granting of the application in Taiwan will further strengthen Nexam Chemicals protection for the crosslinking technology developed by the company. In addition, Nexam Chemical has applied for PETA patents in other markets - including China, Japan, South Korea, Russia and Brazil.



For more information, please contact:

Lennart Holm

Chairman of the Board:

+46 (0)706 30 8562



Per Palmqvist Morin

CEO

+46 (0)706 55 55 82



Nexam Chemical is a Swedish company with a world-leading technology within its area for heat-activated crosslinking of plastics and polymers. The company develops, manufactures and markets unique heat-activated crosslinkers to the plastics market. A company description and more information about the business will be found on www.nexamchemical.com. The Company's Certified Adviser is Remium Nordic AB. Note: This press release has been translated from Swedish. The Swedish text shall govern for all purposes and prevail in case of any discrepancy with the English version.


All Topics